Basic Concepts and Clinical Outcomes of Drug-Eluting Balloons for Treatment of Coronary Artery Disease: An Overview
- PMID: 28764234
- PMCID: PMC5535426
- DOI: 10.7860/JCDR/2017/26321.10000
Basic Concepts and Clinical Outcomes of Drug-Eluting Balloons for Treatment of Coronary Artery Disease: An Overview
Abstract
The technology of percutaneous coronary intervention for atherosclerotic coronary artery disease has evolved considerably since its inception. Though Drug-Eluting Stent (DES) reduces the rate of restenosis, long-term safety outcomes and persistent restenosis in complex lesion subset remain area of concern. Recently, Drug-Eluting Balloon (DEB) represents a novel treatment strategy for atherosclerotic coronary artery disease. DEB demonstrated its added value in preclinical studies. Inspired by these results, several clinical trials particularly in complex lesion subsets have been started to explore the value of this novel treatment strategy in a broader range of lesions. This review would summarise material compositions and different characteristics and clinical outcomes of currently available DEB.
Keywords: Balloon angioplasty; Balloon catheter; Drug-coated balloon; Percutaneous coronary intervention.
References
-
- Gruntzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med. 1979;301(2):61–68. - PubMed
-
- Meier B. The first patient to undergo coronary angioplasty-23-year follow-up. N Engl J Med. 2001;344(2):144–45. - PubMed
-
- Sigwart U, Urban P, Golf S, Kaufmann U, Imbert C, Fischer A, et al. Emergency stenting for acute occlusion after coronary balloon angioplasty. Circulation. 1988;78(5 Pt 1):1121–27. - PubMed
-
- Iqbal J, Gunn J, Serruys PW. Coronary stents: historical development, current status and future directions. Br Med Bull. 2013;106:193–211. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases